DFX Intelligence
Venture Capital Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.
Companies / B••••••••
B••••••••
B•••••••• Genetics is developing Gentrafix™, a groundbreaking technology that delivers DNA to every affected cell, which can be used to treat genetic diseases.
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- unknown
- Rounds on record
- 0
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 1
Financing history
0 rounds
No dated round yet.
Investors on record
1 edges
- F••••• P••••• C•••••• L•••••• portfolio listing Fact futureplanetcapital.com
People
0 officers, 0 directors
No officer or director on record.
Timeline
0
No dated event.
Evidence
5 observations
Every observation on this company
- Description: B•••••••• Genetics is developing Gentrafix™, a groundbreaking technology that delivers DNA to every affected cell, which can be used to treat genetic diseases. Sep 17, 2026 Fact Portfolio company websites (about, investors, press pages)
- Listed on portfolio page: F••••• P••••• C•••••• L•••••• Sep 16, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: F••••• P••••• C•••••• L•••••• Sep 14, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Website status: ok Sep 17, 2026 Fact Portfolio company websites (about, investors, press pages)
- Site title: Revolutionising the Treatment of Genetic Diseases | B•••••••• Genetics Sep 17, 2026 Fact Portfolio company websites (about, investors, press pages)